Correlation Between NYSE Composite and Northwest Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Northwest Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Northwest Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Northwest Biotherapeutics, you can compare the effects of market volatilities on NYSE Composite and Northwest Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Northwest Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Northwest Biotherapeutics.
Diversification Opportunities for NYSE Composite and Northwest Biotherapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Northwest is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Northwest Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Northwest Biotherapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Northwest Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Northwest Biotherapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Northwest Biotherapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Northwest Biotherapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.14 times more return on investment than Northwest Biotherapeutics. However, NYSE Composite is 7.21 times less risky than Northwest Biotherapeutics. It trades about 0.07 of its potential returns per unit of risk. Northwest Biotherapeutics is currently generating about -0.01 per unit of risk. If you would invest 1,925,638 in NYSE Composite on September 16, 2024 and sell it today you would earn a total of 47,299 from holding NYSE Composite or generate 2.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Northwest Biotherapeutics
Performance |
Timeline |
NYSE Composite and Northwest Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Northwest Biotherapeutics
Pair trading matchups for Northwest Biotherapeutics
Pair Trading with NYSE Composite and Northwest Biotherapeutics
The main advantage of trading using opposite NYSE Composite and Northwest Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Northwest Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northwest Biotherapeutics will offset losses from the drop in Northwest Biotherapeutics' long position.NYSE Composite vs. Employers Holdings | NYSE Composite vs. Palomar Holdings | NYSE Composite vs. United Fire Group | NYSE Composite vs. Ross Stores |
Northwest Biotherapeutics vs. Equillium | Northwest Biotherapeutics vs. DiaMedica Therapeutics | Northwest Biotherapeutics vs. Valneva SE ADR | Northwest Biotherapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |